- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-29-0039892

Ortis Pharma Private Limited
About Ortis Pharma Private Limited
Data last updated:
Ortis Pharma Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 06 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24299UP2021PTC150293.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Abhishek Bose and Tammu Shree.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at R/O – Khno – 360/2, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.22 Lakh, a growth of 13% compared to the previous year. For the same year it recorded a net loss of ₹29,375 (net margin -1.2%) and EBITDA of -₹28,831 (EBITDA margin -1.2%). Revenue has grown at a compounded annual rate (CAGR) of 46% over three years.
Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it; 4 cases are pending.
Ortis Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0039892). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Ortis Pharma
Contact details
Ortis Pharma Private Limited's registered office is in Ghaziabad, Uttar Pradesh.
- Registered AddressR/O – Khno – 360/2, Laxmi Garden Loni Gaziabad Uttar Pradesh, Ghaziabad, Uttar Pradesh, India – 201102
- IndustryChemicals, Other Chemical Product, Manufacturing, Fine Chemicals And Other Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ortis Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ortis Pharma Private Limited, buy the company report.
Financials of Ortis Pharma Private Limited
FY 2025 filings availableOrtis Pharma Private Limited reported revenue of ₹24.22 Lakh (up 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 46% over three years, including 13% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹28,831 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹29,375 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -1.2% | |||
| Net Profit Margin | -1.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Ortis Pharma Private Limited, buy the company report.
Board of directors of Ortis Pharma Private Limited
Ortis Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhishek Bose | Director | 06 Aug 2021 | 5 Years 2 Months | Current |
| Tammu Shree | Director | 18 Mar 2024 | 2 Years 7 Months | Current |
Peer comparison
Ortis Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Garrix Pharma Private Limited | ₹24.35 Lakh (FY 2024) | 59.0% | New Delhi, Delhi, India | |||
| Nikit Chem Retails Private Limited | ₹24.32 Lakh (FY 2024) | 131.0% | Ludhiana, Punjab, India | |||
| Thoshe Air Purifications Private Limited | ₹24.25 Lakh (FY 2024) | 40.0% | Pen, Maharashtra, India | |||
| Virgin Minerals Private Limited | ₹24.25 Lakh (FY 2025) | -41.0% | Jaipur, Rajasthan, India | |||
| Satv Lifesciences Private Limited | ₹24.22 Lakh (FY 2023) | 159.0% | Pune, Maharashtra, India | |||
| Ortis Pharma Private Limitedthis company | ₹24.22 Lakh (FY 2025) | -₹29,375 | -1.2% | 13.0% | Ghaziabad, Uttar Pradesh, India | |
| Sainbiomed Private Limited | ₹24.2 Lakh (FY 2022) | 19.0% | Dehradun, Uttarakhand, India | |||
| I2 Private Limited | ₹24.15 Lakh (FY 2025) | 78.0% | New Delhi, Delhi, India | |||
| Amro Kings Limited | ₹24.12 Lakh (FY 2021) | 12697242.0% | Chennai, Tamil Nadu, India | |||
| True Pharma H&H (OPC) Private Limited | ₹24.12 Lakh (FY 2025) | -52.0% | Puducherry, India | |||
| Austellus Medical Research and Pharmaceuticals Private Limited | ₹24.12 Lakh (FY 2024) | -19.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Ortis Pharma Private Limited, buy the company report.
Legal cases
Ortis Pharma Private Limited has 5 court cases on record: 1 filed by Ortis Pharma, 4 filed against it. 4 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 4 | 4 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Shahdara, Delhi | Cheque dishonour complaint | Filed by the company against M/S Samskruthy Pharma Private Limited and 1 other | Disposed |
| District court, Rohtak, Haryana | Civil suit | Filed against the company by M/S Friends Medi Healthcare, Through Its Prop. Mandeep Kumar | Pending |
| District court, Rohtak, Haryana | Civil suit | Filed against the company by M/S Friends Medi Healthcare, Through Its Prop, Mandeep Kumar | Pending |
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed against the company by an individual | Pending |
| District court, Hisar, Haryana | Court case (N ACT) | Filed against the company by Medishri Healthcare Pvt, PTD. | Pending |
To see the full case history of Ortis Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ortis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ortis Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ortis Pharma Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Akanksha Pandey ceased to be Director on 18 Mar 2024.
Frequently asked questions
Ortis Pharma is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 06 August 2021 (5+ years old) and is registered under CIN U24299UP2021PTC150293.
Ortis Pharma has 2 current directors:
- Abhishek Bose - Director
- Tammu Shree - Director
The latest financial statements of Ortis Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Ortis Pharma is U24299UP2021PTC150293. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ortis Pharma has 5 court cases on record: 1 filed by the company and 4 filed against it. 4 are pending.
Ortis Pharma was incorporated on 06 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Ortis Pharma by revenue are Garrix Pharma Private Limited, Nikit Chem Retails Private Limited, Thoshe Air Purifications Private Limited, Virgin Minerals Private Limited, Satv Lifesciences Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Akanksha Pandey ceased to be Director on 18 Mar 2024. Tammu Shree was appointed as Director on 18 Mar 2024. Abhishek Bose was appointed as Director on 06 Aug 2021.
Yes, Ortis Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-29-0039892).
The registered office of Ortis Pharma is at RO – Khno – 3602, Laxmi Garden Loni Gaziabad Uttar Pradesh, Ghaziabad, Uttar Pradesh, India – 201102.
Ortis Pharma operates in the chemicals industry, in the other chemical product segment.